BBI join EMD Millipore and Kinematic to educate in the field of lateral flow and ensuring faster, higher performing and more robust systems

The October seminar will educate registrants on how to develop and manufacture a lateral flow test and provide new insights into how superior quality components, established research and development processes and highly efficient machinery, guarantee faster, higher performing and more robust assay systems.

The practical elements of the course will allow theory to be put into practice as a lateral flow test is built; culminating with the end user being able to read this test with BBI’s new Novarum smartphone reader.

The Seminar, taking place on the 2nd and 3rd October in San Diego, incorporates BBI’s understanding of market requirements as well as the available new technologies which are enhancing lateral flow. “We are constantly updating lateral flow technology to improve performance whilst ensuring the cost per test allows for market penetration” commented Morag Leaver, BBI’s Head of R&D. “This seminar will allow us to share our experience and highlight the advancements within the field of lateral flow”.

The seminar is designed for professionals involved in the development and manufacture of lateral flow test kits. Scientists, engineers and technicians working in R&D and product development will also benefit. Presentations are by PATH, EMD Millipore, BBInternational and Kinematic.

In more detail, the seminar will cover the following elements, providing an all-encompassing perspective for those working towards development of the best performing assay:

Contract R&D for lateral flow – design phases, qualitative versus quantitative assays plus regulatory considerations;
Design considerations for lateral flow test strips;
Design for manufacturability;
Membrane technology - manufacturing, properties, testing, storage and handling;
Reagent chemistries and labels of choice for lateral flow;
Antibodies and blockers;
Matrix modules, primer to lab, striping machinery and settings;
Pad materials – important properties and selection;
QC testing considerations – patient samples, characterization;
Contract manufacturing and test validation;
Equipment validation;
NEW Novarum Reader, molecular and future technologies.

The event will also provide networking opportunities in the form of a cocktail and canapé reception on the first evening. For more information visit www.bbigold.com/seminar.

BBInternational is an organisation comprised of BBI Gold, BBI Enzymes, SCIPAC and BBI Healthcare, which can be found online at www.bbigold.com, www.bbienzymes.com, www.scipac.com, www.hypobox.com and www.hyposite.com respectively.

BBInternational is a leading global supplier and manufacturer of high quality gold reagents which are used within lateral flow rapid diagnostic tests at the point of care (POC). Over the years BBInterational – with its own unique recipe gold colloid – has developed an enviable reputation as the supplier of choice in the global diagnostics marketplace.

BBI Enzymes was launched in 2009 and in just a short time has developed a global customer base of blue chip customers operating in the highly regulated diagnostic and pharmaceutical markets. The foundation of stringent adherence to internationally accredited policy procedures has led to high demand for BBI Enzymes’ range of products, which includes purified human antigens, matching antibodies, serum/plasma products, disease state and patient samples. The Company operates a quality management system which complies with the current requirements of BS EN ISO 9001 and has been registered with the British Standard Institute (BSI) since January 1993.

BBI Healthcare provides a range of fast acting glucose tablets as well as specialist women’s health products and a range of nutritional supplements both in the UK and abroad, with the aim of ‘making life easier’ for individuals who need to keep a careful eye on their health and wellbeing.

BBInternational
73 Ty Glas Avenue
Llanishen
Cardiff
CF145DX

This release was published on openPR.